Robert S. Seitz

2.7k total citations
42 papers, 1.8k citations indexed

About

Robert S. Seitz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Robert S. Seitz has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Robert S. Seitz's work include Cancer Immunotherapy and Biomarkers (13 papers), HER2/EGFR in Cancer Research (7 papers) and Ferroptosis and cancer prognosis (6 papers). Robert S. Seitz is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), HER2/EGFR in Cancer Research (7 papers) and Ferroptosis and cancer prognosis (6 papers). Robert S. Seitz collaborates with scholars based in United States, Canada and China. Robert S. Seitz's co-authors include Michael P. Lisanti, Shengwen Calvin Li, Douglas T. Ross, Brian Z. Ring, Rodney A. Beck, Jeff M. Bronstein, Torsten O. Nielsen, Roger L. Lallone, David R. Hout and Subbaya Subramanian and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Robert S. Seitz

41 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert S. Seitz United States	21	875	493	461	396	329	42	1.8k
Thomas De Raedt United States	21	1.1k 1.2×	280 0.6×	287 0.6×	695 1.8×	163 0.5×	30	2.4k
Qunsheng Ji China	25	1.5k 1.7×	686 1.4×	560 1.2×	538 1.4×	224 0.7×	50	2.5k
Rita A. Busuttil Australia	22	1.7k 1.9×	577 1.2×	566 1.2×	369 0.9×	125 0.4×	39	2.5k
Hisaki Igarashi Japan	25	945 1.1×	389 0.8×	289 0.6×	322 0.8×	187 0.6×	52	1.5k
Kai Wiechen Germany	14	533 0.6×	337 0.7×	226 0.5×	284 0.7×	378 1.1×	22	1.2k
Manabu Futamura Japan	28	1.4k 1.6×	1.1k 2.1×	729 1.6×	372 0.9×	213 0.6×	126	2.7k
Sang-Bae Kim United States	21	1.2k 1.4×	629 1.3×	551 1.2×	498 1.3×	213 0.6×	23	2.1k
Yisong Wang United States	26	1.1k 1.3×	793 1.6×	241 0.5×	304 0.8×	170 0.5×	52	2.1k
Leonard Girnita Sweden	36	2.5k 2.9×	781 1.6×	898 1.9×	352 0.9×	277 0.8×	72	3.7k
Jonathan A. Fletcher United States	8	1.2k 1.4×	517 1.0×	327 0.7×	435 1.1×	162 0.5×	12	2.0k

Countries citing papers authored by Robert S. Seitz

Since Specialization

Citations

This map shows the geographic impact of Robert S. Seitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Seitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Seitz more than expected).

Fields of papers citing papers by Robert S. Seitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Seitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Seitz. The network helps show where Robert S. Seitz may publish in the future.

Co-authorship network of co-authors of Robert S. Seitz

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Seitz. A scholar is included among the top collaborators of Robert S. Seitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Seitz. Robert S. Seitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ring, Brian Z., et al.. (2025). Immune infiltrate populations within distinct tumor immune microenvironments predictive of immune checkpoint treatment outcome. Scientific Reports. 15(1). 3126–3126. 1 indexed citations

Seitz, Robert S., Michael E. Hurwitz, Daniel Bailey, et al.. (2022). Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients. Journal of Translational Medicine. 20(1). 370–370. 7 indexed citations

Saltman, David L., Matthew G. Varga, Nicole S. Croteau, et al.. (2022). 27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study. Clinical Lung Cancer. 24(2). 137–144. 2 indexed citations

Jain, Amit, Emily J. Miller, Robert S. Seitz, et al.. (2022). Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer. BMC Cancer. 22(1). 407–407. 7 indexed citations

Bianchini, Giampaolo, Matteo Dugo, Chiun‐Sheng Huang, et al.. (2021). LBA12 Predictive value of gene-expression profiles (GEPs) and their dynamics during therapy in the NeoTRIPaPDL1 trial. Annals of Oncology. 32. S1283–S1284. 15 indexed citations

Iwase, Toshiaki, Lajos Pusztai, Kim Blenman, et al.. (2020). Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer.. Journal of Clinical Oncology. 38(15_suppl). 3117–3117. 1 indexed citations

Fernández, José Rodrigo Espinosa, Bedrich L. Eckhardt, Jangsoon Lee, et al.. (2020). Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research. PLoS ONE. 15(4). e0231953–e0231953. 23 indexed citations

Jovanović, Bojana, Quanhu Sheng, Robert S. Seitz, et al.. (2017). Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue. BMC Cancer. 17(1). 241–241. 28 indexed citations

Ring, Brian Z., David R. Hout, Stephan W. Morris, et al.. (2016). Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients. BMC Cancer. 16(1). 143–143. 52 indexed citations

10.

Wang, Xi, Brian Z. Ring, Robert S. Seitz, et al.. (2015). Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients. BMC Clinical Pathology. 15(1). 21–21. 4 indexed citations

11.

Samimi, Goli, Brian Z. Ring, D. T. Ross, et al.. (2012). TLE3 Expression Is Associated with Sensitivity to Taxane Treatment in Ovarian Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 21(2). 273–279. 17 indexed citations

12.

Beck, Rodney A., et al.. (2012). A Search for Reliable Molecular Markers of Prognosis in Prostate Cancer. American Journal of Clinical Pathology. 137(6). 918–930. 33 indexed citations

13.

Shon, Wonwoo, Sarah M. Jenkins, Douglas T. Ross, et al.. (2011). Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness. Journal of Cutaneous Pathology. 38(12). 961–966. 19 indexed citations

14.

Hicks, David G., Swati Kulkarni, Thaer Khoury, et al.. (2010). The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence. BMC Cancer. 10(1). 108–108. 31 indexed citations

15.

Frolova, Natalya, Mick D. Edmonds, Thomas M. Bodenstine, et al.. (2009). A Shift from Nuclear to Cytoplasmic Breast Cancer Metastasis Suppressor 1 Expression Is Associated with Highly Proliferative Estrogen Receptor-Negative Breast Cancers. Tumor Biology. 30(3). 148–159. 38 indexed citations

16.

Ring, Brian Z., Robert S. Seitz, Rodney A. Beck, et al.. (2009). A novel five-antibody immunohistochemical test for subclassification of lung carcinoma. Modern Pathology. 22(8). 1032–1043. 73 indexed citations

17.

Ring, Brian Z., Stella Chang, Ludwig Ring, Robert S. Seitz, & Douglas T. Ross. (2008). Gene expression patterns within cell lines are predictive of chemosensitivity. BMC Genomics. 9(1). 74–74. 12 indexed citations

18.

Hanker, Ariella B., et al.. (2008). Tools to Study the Function of the Ras‐Related, Estrogen‐Regulated Growth Inhibitor in Breast Cancer. Methods in enzymology on CD-ROM/Methods in enzymology. 439. 53–72. 6 indexed citations

19.

Rocconi, Rodney P., Tyler O. Kirby, Robert S. Seitz, et al.. (2008). Lipoxygenase Pathway Receptor Expression in Ovarian Cancer. Reproductive Sciences. 15(3). 321–326. 38 indexed citations

20.

Stevens, David B., et al.. (1999). Oligodendrocyte-Specific Protein Peptides Induce Experimental Autoimmune Encephalomyelitis in SJL/J Mice. The Journal of Immunology. 162(12). 7501–7509. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact